ATA510975A - METHOD FOR THE PRODUCTION OF MEDICINAL FORMS FOR ENTERAL ADMINISTRATION - Google Patents
METHOD FOR THE PRODUCTION OF MEDICINAL FORMS FOR ENTERAL ADMINISTRATIONInfo
- Publication number
- ATA510975A ATA510975A AT510975A AT510975A ATA510975A AT A510975 A ATA510975 A AT A510975A AT 510975 A AT510975 A AT 510975A AT 510975 A AT510975 A AT 510975A AT A510975 A ATA510975 A AT A510975A
- Authority
- AT
- Austria
- Prior art keywords
- production
- enteral administration
- medicinal forms
- medicinal
- forms
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH920474 | 1974-07-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
ATA510975A true ATA510975A (en) | 1980-03-15 |
AT359196B AT359196B (en) | 1980-10-27 |
Family
ID=4349465
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT510975A AT359196B (en) | 1974-07-04 | 1975-07-03 | METHOD FOR THE PRODUCTION OF MEDICINAL FORMS FOR ENTERAL ADMINISTRATION |
Country Status (18)
Country | Link |
---|---|
JP (1) | JPS5132722A (en) |
AT (1) | AT359196B (en) |
AU (1) | AU507674B2 (en) |
BE (1) | BE831041A (en) |
CA (1) | CA1057196A (en) |
DE (1) | DE2528257C2 (en) |
ES (1) | ES439074A1 (en) |
FR (1) | FR2276833A1 (en) |
GB (1) | GB1513383A (en) |
HK (1) | HK17281A (en) |
HU (1) | HU172531B (en) |
IE (1) | IE41573B1 (en) |
IL (1) | IL47623A (en) |
MY (1) | MY8100372A (en) |
NL (1) | NL7507745A (en) |
PH (1) | PH13763A (en) |
SE (1) | SE436831B (en) |
ZA (1) | ZA754303B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1090703B (en) * | 1976-12-03 | 1985-06-26 | Scherer Ltd R P | IMPROVEMENT IN USEFUL COMPOSITIONS SUCH AS DRUG VEHICLES |
DE2707878C2 (en) * | 1977-02-24 | 1986-01-30 | Kali-Chemie Pharma Gmbh, 3000 Hannover | Use of mono- and / or diglycerides of medium-chain fatty acids |
DK154607C (en) * | 1978-12-21 | 1989-06-05 | Sandoz Ag | PROCEDURE FOR PREPARING A PHARMACEUTICAL FORM FOR ORAL ADMINISTRATION OF ERGOTAL KALOIDS |
JPS56104813A (en) * | 1980-01-25 | 1981-08-20 | Takeda Chem Ind Ltd | Composition for rectal infusion containing compound having beta-lactam ring |
AU543727B2 (en) | 1980-06-02 | 1985-05-02 | Ayerst Mckenna & Harrison Inc. | Injectable composition of rapamycin |
US4366145A (en) * | 1981-06-24 | 1982-12-28 | Sandoz, Inc. | Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation |
DE3829643A1 (en) * | 1988-09-01 | 1990-03-15 | Roecar Holdings Nv | PHYTO AND ZOOSTEROLS AND THEIR DERIVATIVES WITH IMPROVED WATER SOLUBILITY |
-
1975
- 1975-06-25 DE DE2528257A patent/DE2528257C2/en not_active Expired
- 1975-06-27 SE SE7507413A patent/SE436831B/en not_active IP Right Cessation
- 1975-06-30 NL NL7507745A patent/NL7507745A/en not_active Application Discontinuation
- 1975-06-30 GB GB27470/75A patent/GB1513383A/en not_active Expired
- 1975-07-02 IE IE1468/75A patent/IE41573B1/en unknown
- 1975-07-02 PH PH17338A patent/PH13763A/en unknown
- 1975-07-02 ES ES439074A patent/ES439074A1/en not_active Expired
- 1975-07-02 IL IL47623A patent/IL47623A/en unknown
- 1975-07-02 HU HU75SA00002815A patent/HU172531B/en not_active IP Right Cessation
- 1975-07-03 FR FR7520947A patent/FR2276833A1/en active Granted
- 1975-07-03 AT AT510975A patent/AT359196B/en not_active IP Right Cessation
- 1975-07-03 AU AU82736/75A patent/AU507674B2/en not_active Expired
- 1975-07-03 JP JP50081486A patent/JPS5132722A/ja active Pending
- 1975-07-03 CA CA230,702A patent/CA1057196A/en not_active Expired
- 1975-07-04 ZA ZA754303A patent/ZA754303B/en unknown
- 1975-07-04 BE BE158021A patent/BE831041A/en not_active IP Right Cessation
-
1981
- 1981-04-30 HK HK172/81A patent/HK17281A/en unknown
- 1981-12-30 MY MY372/81A patent/MY8100372A/en unknown
Also Published As
Publication number | Publication date |
---|---|
AT359196B (en) | 1980-10-27 |
CA1057196A (en) | 1979-06-26 |
IE41573L (en) | 1976-01-04 |
GB1513383A (en) | 1978-06-07 |
NL7507745A (en) | 1976-01-06 |
HK17281A (en) | 1981-05-08 |
FR2276833B1 (en) | 1978-11-10 |
IE41573B1 (en) | 1980-01-30 |
DE2528257C2 (en) | 1986-02-13 |
PH13763A (en) | 1980-09-18 |
SE7507413L (en) | 1976-01-05 |
BE831041A (en) | 1976-01-05 |
FR2276833A1 (en) | 1976-01-30 |
JPS5132722A (en) | 1976-03-19 |
AU507674B2 (en) | 1980-02-21 |
SE436831B (en) | 1985-01-28 |
DE2528257A1 (en) | 1976-01-22 |
ES439074A1 (en) | 1977-05-16 |
HU172531B (en) | 1978-09-28 |
IL47623A0 (en) | 1975-10-15 |
IL47623A (en) | 1979-05-31 |
MY8100372A (en) | 1981-12-31 |
AU8273675A (en) | 1977-01-06 |
ZA754303B (en) | 1977-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AT326270B (en) | METHOD FOR MANUFACTURING MEDICINAL FORMS | |
ATA939775A (en) | PROCESS FOR THE PRODUCTION OF NEW 3-AMINO-INDAZOLE CARBONIC ACID DERIVATIVES | |
DD129648A5 (en) | PROCESS FOR THE PREPARATION OF PROSTAGLANDINE DERIVATIVES | |
AT363889B (en) | METHOD FOR THE PRODUCTION OF ENZYMPREPARATES | |
AT366576B (en) | METHOD FOR PRODUCING PHARMACEUTICAL PREPARATIONS | |
AT329780B (en) | PROCESS FOR THE MANUFACTURING OF INSULIN, INSULIN ANALOGS AND DERIVATIVES | |
ATA916173A (en) | PROCESS FOR THE MANUFACTURING OF INSULIN, INSULIN ANALOGS AND DERIVATIVES | |
AT333448B (en) | PROCESS FOR THE MANUFACTURING OF INSULIN, INSULIN ANALOGS AND DERIVATIVES | |
AT344317B (en) | METHOD FOR THE PRODUCTION OF MEDICINAL PRODUCTS | |
AT359196B (en) | METHOD FOR THE PRODUCTION OF MEDICINAL FORMS FOR ENTERAL ADMINISTRATION | |
AT306228B (en) | Process for the manufacture of pharmaceutical preparations | |
AT333749B (en) | PROCESS FOR THE PREPARATION OF NEW 2-ARYLAMINO-2-IMIDAZOLINE DERIVATIVES | |
AT361630B (en) | METHOD FOR THE PRODUCTION OF MEDICINAL PRODUCTS | |
AT342191B (en) | PROCESS FOR MANUFACTURING DRUG COMBINATIONS | |
AT340048B (en) | PROCESS FOR THE PRODUCTION OF PENICILLIN AND CEPHALOSPORIC ACID DERIVATIVES | |
AT309690B (en) | Process for the manufacture of an improved oral administration form of Raubasin | |
AT342205B (en) | METHOD FOR MANUFACTURING MEDICINAL BALLS | |
AT359215B (en) | METHOD FOR THE PRODUCTION OF PGFBETA PROSTALINE | |
AT311971B (en) | Process for the preparation of new tetrahydropyridine derivatives and of acid addition salts of these compounds | |
AT337717B (en) | PROCESS FOR THE PRODUCTION OF HALOGENATHANPHOSPHONIC ACID DIHALOGENIDES AND VINYLPHOSPHONIC ACID DIHALOGENIDES | |
AT347469B (en) | PROCESS FOR THE PREPARATION OF BENZODIAZEPINE DERIVATIVES | |
AT335063B (en) | PROCESS FOR THE PREPARATION OF D (-) - ALFA-AMINO-P-HYDROXYBENZYLPENICILLIN | |
AT348680B (en) | METHOD FOR THE PRODUCTION OF MEDICINAL PRODUCTS | |
AT358569B (en) | METHOD FOR THE PRODUCTION OF 2-AMINOMETHYL-PYRROLIDIN AND ITS ACID ADDITION SALTS | |
ATA517075A (en) | PROCESS FOR THE PREPARATION OF NEW 3-ACYLAMINO-2-AZETIDINONE DERIVATIVES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ELJ | Ceased due to non-payment of the annual fee |